.AstraZeneca has discussed an early look at the performance of its in-house antibody-drug conjugate ...
.After announcing a stage 3 launch based on positive midstage end results, iTeos and GSK are actuall...
.The FDA should be even more open and also collaborative to discharge a rise in approvals of unusual...
.It's an extraordinarily hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara...
.Atea Pharmaceuticals' antiviral has stopped working yet another COVID-19 trial, yet the biotech sti...
.Neurocrine Biosciences' mental illness program pivot has actually stopped working. The biotech was ...
.Sanofi has actually made a late entrance to the radioligand celebration, spending one hundred thous...
.After F2G's initial attempt to acquire a brand-new training class of antifungal to market was hinde...
.Moderna has actually pledged to reduce R&D investing by $1.1 billion through 2027. The decision ...
.Only 4 months after Sanofi wager $80 million in ahead of time cash money on Key Therapeutics' losma...